NCT04370665View on ClinicalTrials.gov

Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease

NAUnknownINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Parkinson Disease
Interventions
DEVICE

Exablate BBBD with Cerezyme

"Blood Brain Barrier Disruption via Exablate to deliver Cerezyme.~Other Names:~Exablate Neuro"

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT04370665 - Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease | Biotech Hunter | Biotech Hunter